Bromfenac sodium
Bromfenac Ophthalmic Solution, 0.07% is a prescription eye drop containing bromfenac sodium, a nonsteroidal anti-inflammatory drug (NSAID). Manufactured by Apotex Corp., it's used to treat eye inflammation and pain after cataract surgery. Available in 1.6 mL or 3 mL bottles. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Bromfenac Ophthalmic Solution, 0.07% is a prescription eye drop containing bromfenac sodium, a nonsteroidal anti-inflammatory drug (NSAID). Manufactured by Apotex Corp., it's used to treat eye inflammation and pain after cataract surgery. Available in 1.6 mL or 3 mL bottles. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Bromfenac sodium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Bromfenac sodium — ANDA 203168 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203168"
}
]
|
| identifier | ANDA203168 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"fda",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Bromfenac sodium |
